Pegylated liposomal doxorubicin in the management of ovarian cancer - Wikidata - awgldk - TriplyDB

Pegylated liposomal doxorubicin in the management of ovarian cancer

Pegylated liposomal doxorubicin in the management of ovarian cancer

http://www.wikidata.org/entity/Q34187661

about

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials A novel PEGylated liposome-encapsulated SANT75 suppresses tumor growth through inhibiting hedgehog signaling pathway Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment.The treatment of breast cancer using liposome technology.Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience.Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

P2860

Q26858830-D5E2AB34-A6AB-4506-B9D0-079A6C55D786 Q28485870-01D3E692-B182-4854-8E2C-3E2FEE4A9FA9 Q28538311-4891F005-93AE-4150-89C8-55F23FB8E5AA Q36585890-C700A559-0559-4FA0-87AA-48C7E1EBDC9E Q37857281-6B1FA51D-71E6-4AE5-8B81-7782D1A02F15 Q38002854-1B730E2D-25EB-48B8-944E-8A75FF9F5EE8 Q39209049-091C56C0-C401-4756-BBC3-637652B32452 Q42416643-ACF368CE-0ECA-456C-83B2-FCEC0CC82094 Q44616736-65D65B34-48DD-4EF0-B945-FA66E0E49C7E

P2860

Pegylated liposomal doxorubicin in the management of ovarian cancer

http://www.wikidata.org/entity/Q34187661

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pegylated liposomal doxorubicin in the management of ovarian cancer

@ast

Pegylated liposomal doxorubicin in the management of ovarian cancer

@en

Pegylated liposomal doxorubicin in the management of ovarian cancer

@nl

type

label

Pegylated liposomal doxorubicin in the management of ovarian cancer

@ast

Pegylated liposomal doxorubicin in the management of ovarian cancer

@en

Pegylated liposomal doxorubicin in the management of ovarian cancer

@nl

prefLabel

Pegylated liposomal doxorubicin in the management of ovarian cancer

@ast

Pegylated liposomal doxorubicin in the management of ovarian cancer

@en

Pegylated liposomal doxorubicin in the management of ovarian cancer

@nl

P1433

Q34187661-337A7FBE-CB89-458C-92EB-942E9A459A95

P1476

Q34187661-5354F208-7254-4D76-849D-8AD1A554B907

P2093

Q34187661-18753E7C-2D88-42A2-8A48-005431A07F27

Q34187661-4CC83153-1B4C-4862-8B30-F5DA2B9C8324

Q34187661-842074A9-458D-499E-AD43-0E7224A4145B

Q34187661-D2C1D5FE-3263-4C5A-B34D-11869CB08C0D

Q34187661-EDF20BDA-8D9A-4BAA-89D6-48F0776029C3

Q34187661-F685C6FE-EC89-40C6-B4AF-F8D3FD45A746

P2860

Q34187661-0231916B-D3FF-4150-879F-57D5ECD206E6

Q34187661-02C5BA05-3C41-4D99-A7FD-94E7BB685B2B

Q34187661-09ADDB65-6039-4178-A7CE-848815F6860C

Q34187661-0D3885C8-73B8-43F9-B92A-6E2CDD47A3F0

Q34187661-0E04FE32-43D5-4B31-8458-B3BC8CBDF0A8

Q34187661-0F325851-2173-4055-A104-2B30298895F6

Q34187661-0FE4A605-868A-42DB-BDCE-9948410D5556

Q34187661-105ABEC7-8C76-434E-BDD2-68DDCF0BDEBA

Q34187661-18D81921-BC6F-4BCC-BB4B-DA92CA5122CB

Q34187661-1B2FEA81-5B2A-438F-9F2C-F8FDD2E23B02

P304

Q34187661-840DCB4C-9104-4ED2-B1FD-99665117CA21

P31

Q34187661-C77357C5-CA83-4050-BA99-9CCA82E2D04A

P356

Q34187661-7118339D-F9A8-4E49-BC0C-E8ED31BE8DD1

P478

Q34187661-07F71CCA-443A-4414-8C99-79F3F86DABBF

P50

Q34187661-1D289180-60A3-4E33-A671-90421B32F02B

P577

Q34187661-6D0F59B0-20A2-4762-901F-DEF35E7D5D4C

P698

Q34187661-591BFDBF-0758-4055-9EE3-EECB5B30CBDE

P921

Q34187661-5CA67F23-9A05-4938-A8CC-CC5A42C57883

P932

Q34187661-2B5A3B60-A739-432C-8B75-0541DC34987F

P356

P1433

Therapeutics and Clinical Risk Management

P1476

Pegylated liposomal doxorubicin in the management of ovarian cancer

@en

P2093

Angelo Licameli

http://www.w3.org/2001/XMLSchema#string

Gabriella Ferrandina

http://www.w3.org/2001/XMLSchema#string

Giacomo Corrado

http://www.w3.org/2001/XMLSchema#string

Gilda Fuoco

http://www.w3.org/2001/XMLSchema#string

Giovanni Scambia

http://www.w3.org/2001/XMLSchema#string

Salvatore Pisconti

http://www.w3.org/2001/XMLSchema#string

P2860

Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts

Cancer statistics, 2009

Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.

A phase I study of liposomal doxorubicin (Doxil) with topotecan.

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies.

Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

P304

463-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S3348

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Domenica Lorusso

P577

2010-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20957139

http://www.w3.org/2001/XMLSchema#string

P921

P932

2952486

http://www.w3.org/2001/XMLSchema#string